These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 12791100
21. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica. Ravdin JI, Shain DC, Kelsall BL. Vaccine; 1993; 11(2):241-6. PubMed ID: 8438621 [Abstract] [Full Text] [Related]
22. Progress towards development of a vaccine for amebiasis. Stanley SL. Clin Microbiol Rev; 1997 Oct; 10(4):637-49. PubMed ID: 9336666 [Abstract] [Full Text] [Related]
23. Immunogenicity of an optimized Entamoeba histolytica gal-lectin DNA vaccine. Gaucher D, Chadee K. Arch Med Res; 2000 Oct; 31(4 Suppl):S307-8. PubMed ID: 11070327 [No Abstract] [Full Text] [Related]
24. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess. Soong CJ, Kain KC, Abd-Alla M, Jackson TF, Ravdin JI. J Infect Dis; 1995 Mar; 171(3):645-51. PubMed ID: 7876611 [Abstract] [Full Text] [Related]
25. Evaluation of the PEΔIII-LC3-KDEL3 Chimeric Protein of Entamoeba histolytica-Lectin as a Vaccine Candidate against Amebic Liver Abscess. Martínez-Hernández SL, Becerra-González VM, Muñoz-Ortega MH, Loera-Muro VM, Ávila-Blanco ME, Medina-Rosales MN, Ventura-Juárez J. J Immunol Res; 2021 Mar; 2021():6697900. PubMed ID: 33824880 [Abstract] [Full Text] [Related]
26. Infection and immunity mediated by the carbohydrate recognition domain of the Entamoeba histolytica Gal/GalNAc lectin. Dodson JM, Lenkowski PW, Eubanks AC, Jackson TF, Napodano J, Lyerly DM, Lockhart LA, Mann BJ, Petri WA. J Infect Dis; 1999 Feb; 179(2):460-6. PubMed ID: 9878032 [Abstract] [Full Text] [Related]
27. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica. Miller-Sims VC, Petri WA. Curr Opin Immunol; 2002 Oct; 14(5):549-52. PubMed ID: 12183151 [Abstract] [Full Text] [Related]
28. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess. Roncolato EC, Teixeira JE, Barbosa JE, Zambelli Ramalho LN, Huston CD. Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550 [Abstract] [Full Text] [Related]
32. Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis. Lotter H, Rüssmann H, Heesemann J, Tannich E. Int J Med Microbiol; 2008 Jan; 298(1-2):79-86. PubMed ID: 17900982 [Abstract] [Full Text] [Related]
38. Structure and function of the Entamoeba histolytica Gal/GalNAc lectin. Mann BJ. Int Rev Cytol; 2002 Jan; 216():59-80. PubMed ID: 12049210 [Abstract] [Full Text] [Related]
39. Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy. Abhyankar MM, Orr MT, Kinsey R, Sivananthan S, Nafziger AJ, Oakland DN, Young MK, Farr L, Uddin MJ, Leslie JL, Burgess SL, Liang H, De Lima I, Larson E, Guderian JA, Lin S, Kahn A, Ghosh P, Reed S, Tomai MA, Pedersen K, Petri WA, Fox CB. Front Immunol; 2021 Jan; 12():683157. PubMed ID: 34248966 [Abstract] [Full Text] [Related]